Search Results

A randomized double-blinded trial to assess recurrence of systemic allergic reactions following COVID-19 mRNA vaccination.

• Authors : Khalid MB; Food Allergy Research Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.; Zektser E

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/immunology ; BNT162 Vaccine*

• Source: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2024 Jun; Vol. 153 (6), pp. 1634-1646. Date of Electronic Publication: 2024 Mar 07.Publisher: Mosby Country of Publication: United States NLM ID: 1275002 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6825

Record details

A Bivalent Omicron-BA.4/BA.5-Adapted BNT162b2 Booster in ≥12-Year-Olds.

• Authors : Usdan L; Patel S ...

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; COVID-19*/COVID-19*/COVID-19*/prevention & control

• Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 May 15; Vol. 78 (5), pp. 1194-1203.Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Heterologous and BNT162b2 boosters are more effective than non-mRNA homologous boosters for Omicron.

• Authors : Paternina-Caicedo A; ALZAK Foundation, Cartagena, Colombia; Universidad del Sinu, Cartagena, Colombia.

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; COVID-19*/COVID-19*/COVID-19*/virology ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics SARS-CoV-2 variants

• Source: The Journal of infection [J Infect] 2024 Jun; Vol. 88 (6), pp. 106165. Date of Electronic Publication: 2024 Apr 24.Publisher: W.B. Saunders Country of Publication: England NLM ID: 7908424 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategy.

• Authors : Sieghart D; Department of Internal Medicine III, Division of Rheumatology, Medical University Vienna, Vienna, Austria.; Hana CA

Subjects: Immunization, Secondary* ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/immunology SARS-CoV-2 variants

• Source: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology [J Clin Virol] 2024 Aug; Vol. 173, pp. 105661. Date of Electronic Publication:Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 9815671 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Immunogenicity of Two Doses of BNT162b2 mRNA COVID-19 Vaccine with a ChAdOx1-S Booster Dose among Navy Personnel in Mexico.

• Authors : Ventura-Enríquez Y; Banco de Sangre, Centro Médico Naval (CEMENAV), Coyoacán, Ciudad de México 04470, Mexico.; Cortina-De la Rosa E

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; COVID-19*/COVID-19*/COVID-19*/prevention & control

• Source: Viruses [Viruses] 2024 Apr 01; Vol. 16 (4). Date of Electronic Publication: 2024 Apr 01.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

Record details

Booster effect of the third dose of SARS-CoV-2 mRNA vaccine in Japanese kidney transplant recipients.

• Authors : Kawabe M; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.; Kuroda T

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Kidney Transplantation* COVID-19 vaccine booster shot

• Source: Scientific reports [Sci Rep] 2023 Jun 20; Vol. 13 (1), pp. 9976. Date of Electronic Publication: 2023 Jun 20.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

COVID-19 update: Pfizer bivalent vaccine booster dose for children 6 months to 4 years old.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; Immunization, Secondary*COVID-19 vaccine booster shot

• Source: The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2023 Apr 17; Vol. 65 (1674), pp. 63-64.Publisher: The Medical Letter Country of Publication: United States NLM ID: 2985240R Publication Model: Print Cited Medium: Internet ISSN:

Record details

Six-Month Follow-up after a Fourth BNT162b2 Vaccine Dose.

• Authors : Canetti M; Sheba Medical Center Tel Hashomer, Ramat Gan, Israel.; Barda N

Subjects: Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/immunology ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/therapeutic use

• Source: The New England journal of medicine [N Engl J Med] 2022 Dec 01; Vol. 387 (22), pp. 2092-2094. Date of Electronic Publication: 2022 Nov 09.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium:

Record details

Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines.

• Authors : Kelly JD; San Francisco VA Medical Center, San Francisco, California.; Department of Epidemiology and Biostatistics, University of California, San Francisco.

Subjects: 2019-nCoV Vaccine mRNA-1273*/2019-nCoV Vaccine mRNA-1273*/2019-nCoV Vaccine mRNA-1273*/therapeutic use ; Ad26COVS1*/Ad26COVS1*/Ad26COVS1*/therapeutic use ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/therapeutic use SARS-CoV-2 variants

• Source: JAMA [JAMA] 2022 Oct 11; Vol. 328 (14), pp. 1427-1437.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Immune boosting by B.1.1.529 ( Omicron) depends on previous SARS-CoV-2 exposure.

• Authors : Reynolds CJ; Pade C ...

Subjects: B-Lymphocytes*/B-Lymphocytes*/B-Lymphocytes*/immunology ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/therapeutic use SARS-CoV-2 variants

• Source: Science (New York, N.Y.) [Science] 2022 Jul 15; Vol. 377 (6603), pp. eabq1841. Date of Electronic Publication: 2022 Jul 15.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic

Record details